Clinical trial NCT04379479 - References

COVID-19 — Clinical Effect of Dialyzable Leukocyte Extract in Suspected or Confirmed Cases of COVID-19 (FUTURE-T)

Citation(s)

•   Avila S, Muñoz-García L, Vázquez-Leyva S, Salinas-Jazmín N, Medina-Rivero E, Pavón L, Mellado-Sánchez G, Chacón-Salinas R, Estrada-Parra S, Vallejo-Castillo L, Pérez-Tapia SM
  Transferon™, a peptide mixture with immunomodulatory properties is not immunogenic when administered with various adjuvants. J Immunotoxicol. 2017 Dec;14(1):169-177. doi: 10.1080/1547691X.2017.1346009.
•   Carballo-Uicab G, Linares-Trejo JE, Mellado-Sánchez G, López-Morales CA, Velasco-Velázquez M, Pavón L, Estrada-Parra S, Pérez-Tapia SM, Medina-Rivero E
  Validation of a Cell Proliferation Assay to Assess the Potency of a Dialyzable Leukocyte Extract Intended for Batch Release. Molecules. 2019 Sep 20;24(19). pii: E3426. doi: 10.3390/molecules24193426.
•   Homberg T, Sáenz V, Galicia-Carreón J, Lara I, Cervantes-Trujano E, Andaluz MC, Vera E, Pineda O, Ayala-Balboa J, Estrada-García A, Estrada-Parra S, Pérez-Tapia M, Jiménez-Martínez MC
  The adverse event profile in patients treated with Transferon TM (Dialyzable leukocyte extracts): A preliminary report. Pharmacology & Pharmacy. 2015; 6(02): 65.
•   Medina-Rivero E, Merchand-Reyes G, Pavón L, Vázquez-Leyva S, Pérez-Sánchez G, Salinas-Jazmín N, Estrada-Parra S, Velasco-Velázquez M, Pérez-Tapia SM
  Batch-to-batch reproducibility of Transferon™. J Pharm Biomed Anal. 2014 Jan;88:289-94. doi: 10.1016/j.jpba.2013.09.004. Epub 2013 Sep 17.
•   Medina-Rivero E, Vallejo-Castillo L, Vázquez-Leyva S, Pérez-Sánchez G, Favari L, Velasco-Velázquez M, Estrada-Parra S, Pavón L, Pérez-Tapia SM
  Physicochemical Characteristics of Transferon™ Batches. Biomed Res Int. 2016;2016:7935181. doi: 10.1155/2016/7935181. Epub 2016 Jul 20.
•   Ramírez-Ramírez D, Vadillo E, Arriaga-Pizano LA, Mayani H, Estrada-Parra S, Velasco-Velázquez MA, Pérez-Tapia SM, Pelayo R
  Early Differentiation of Human CD11c(+)NK Cells with ?d T Cell Activation Properties Is Promoted by Dialyzable Leukocyte Extracts. J Immunol Res. 2016;2016:4097642. Epub 2016 Oct 25.
•   Salinas-Jazmín N, Estrada-Parra S, Becerril-García MA, Limón-Flores AY, Vázquez-Leyva S, Medina-Rivero E, Pavón L, Velasco-Velázquez MA, Pérez-Tapia SM
  Herpes murine model as a biological assay to test dialyzable leukocyte extracts activity. J Immunol Res. 2015;2015:146305. doi: 10.1155/2015/146305. Epub 2015 Apr 23.

Assessment of the Clinical Effect of Dialyzable Leukocyte Extracts in Individuals With Acute Respiratory Infection (Suspected or Confirmed Cases of COVID-19) (FUTURE-T)

Details for clinical trial NCT04379479